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Abstract 
Background: Healthcare is moving toward a value-based system with 
reimbursement based on performance. Charitable organizations providing health services 
need to demonstrate positive outcomes for continued grant funding. Measurement-Based 
Care (MBC) is evidence-based, can improve patient outcomes and objectively document 
success. Studies show most psychiatric providers do not utilize MBC in their own 
practices citing lack of time, and a belief that their clinical judgment supersedes a 
measurement tool. The purpose of the study was to establish the use of patient-reported 
symptom measurement tools in a non-profit psychiatric clinic and determine if an office-
based strategy to proactively and regularly report to providers their patient’s scores 
affected treatment outcomes and overall adoption of MBC. 
Methods: The study entailed an explanatory mixed methods design with a pre-test/post-
test quantitative measurement and a semi-structured qualitative interview with providers 
following data collection. Office staff facilitated completion and electronic medical 
record entry of the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety 
Disorder-7 (GAD-7) patient self-report measurement tools for depression and anxiety on 
each patient at every visit. Trended scores were proactively reported to providers prior to 
the visit during months 3 through 6. Score comparisons were made prior to and after the 
reporting period. Qualitative questions explored usefulness of MBC and the effectiveness 
of proactive reporting. 
Results: Dependent t-tests measured differences in the means at three measurement 
points. A repeated measures ANOVA tested the effects of client gender, provider 
discipline and treatment modality on scores. Qualitative data was recorded, transcribed, 
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and coded for thematic pattern identification. Results showed significant reduction on 
scores for both depression and anxiety over the full measurement period with statistically 
significant decreases in anxiety scores during the intervention period. A between-factors 
response was found for gender. Qualitative responses showed younger providers more 
likely to use MBC to guide treatment decisions. MBC was viewed as having utility as an 
adjunct. All recommended continued office facilitation but wanted control over choice of 
tool and to see scores in real time.  
Conclusion: An office process that assists with routine collection of patient data, 
consistently reporting it to providers, can facilitate adoption of MBC to guide treatment 
decisions and produce evidence of positive outcomes. Successful change may be obtained 
with a team approach to the removal of barriers.  
Key words:  Measurement-Based Care, outcome monitoring, behavioral health, 
psychiatry 
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Introduction 
The use of measurement-based care (MBC) as a mechanism to monitor clinical 
outcomes extends back to Florence Nightingale and is well established as an evidence-
based practice (Chun and Bafford, 2014). In late 2016, the Joint Commission published 
new standards relating to the use of MBC in behavioral health as it is now considered 
best practice. The new standards mandate evidence of active use of the measurement 
results in informing care and driving treatment (Lavin, Berry & Williams, 2017). The 
standard went into effect January 1, 2018.  
Incorporating evidence-based practice into care can be difficult and require 
creative and targeted change management approaches. This is the foundation of 
implementation science which looks to analyze and define what works, for whom and 
under what circumstances to promote the uptake of scientific knowledge into front line 
practice (Eccles & Mittman, 2006). Factors that impact success include the characteristics 
of the intervention and their complexity and adaptability, the cost, the stakeholders 
involved and the context where it is carried out -which can present its own set of barriers 
and facilitators (Global Alliance for Chronic Diseases [GACD], n.d.).  
There are many indirect stakeholders affected by the success of the incorporation 
of MBC into care in any organization. But the most direct stakeholders include the 
patients completing the measurements and the providers seeing and acting on the results. 
Making sure these actually happen are the primary challenges. 
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Background 
In 2001, the Institute of Medicine introduced the six, healthcare improvement 
aims that summoned the field to provide evidence of its effectiveness in managing 
population health (IOM, 2001). The Affordable Care Act offered payment incentives for 
the documentation of clinical success in a move away from care based on volume toward 
that of value (Kocher, 2010). Over the last 20 years, the literature has established that 
Measurement-Based Care (MBC) is an evidence-based practice that can demonstrate and 
significantly improve patient outcomes (Fortney, 2016; The Kennedy Forum, 2015). 
While many providers state that they agree, studies show that most do not utilize MBC in 
their own practices citing lack of time, and a belief that their clinical judgment supersedes 
a measurement tool (Jensen-Doss, 2018). Using Lippitt’s Nursing Theory of Change and 
Lewin’s Force-field analysis framework of driving and restraining forces (Mitchell, 
2013), this study instituted and measured MBC use and scores both before and after an 
office-based intervention strategy to regularly disseminate to patients and expose 
providers to the sequential scores on the PHQ-9 and GAD-7 of their patients in the out-
patient psychiatric practice of a non-profit, volunteer, charitable clinic. 
Literature Review 
Databases from MEDLINE, CINAHL, PsycINFO and Google Scholar were 
searched using the keywords Measurement-Based Care and Outcome Monitoring 
combined with the terms Psychiatry, Behavioral Health, Anxiety, and Depression in order 
to limit findings to mental health related articles. The search included peer reviewed 
articles written in English between the years 2000 and 2019. Exceptions to this were the 
articles on the psychometrics of the measurement tools substantiating their reliability and 
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validity. The wide span in years was used to capture the range of experiences and issues 
related to establishing measurement-based care in behavioral health. 
The Institute of Medicine’s (IOM) release of To Err is Human: Building a Safer 
Health System (Kohn, 1999) brought to the fore the problems with patient safety and 
quality in healthcare in the United States. This was followed by Crossing the Quality 
Chasm: A New Health System for the 21st Century (Committee on Quality of Healthcare 
in America, 2001) which further illuminated the qualitative and quantitative divide 
between what was established as good healthcare and what people were actually 
receiving. The report laid the foundation for change with the identification of six aims for 
improvement. Healthcare should be safe with safety as a property of the healthcare 
system as a whole.  It should be effective without overuse or underuse of best available 
treatments. It should be patient-centered with the patient playing an active role in their 
care. It should be timely with prompt attention paid to changes in condition. It should be 
efficient such that it reduces waste in time and cost in maximizing health. And it  should 
be equitable for all populations regardless of race, creed, gender and culture. At its core, 
these aims directed a theoretical shift to care based on quality and value rather than 
volume but created a dilemma in determining progress toward that goal. 
Porter, Larsson and Lee (2016) cite evidence from other fields suggesting that 
systematic outcome measurement can be used as a basis for determining performance and 
value improvement. To that end, the National Strategy for Quality Improvement in 
Healthcare, now the National Quality Strategy (NQS), was developed in 2011 with a 
collaboration of over 300 stakeholders in the healthcare arena. Led by the Agency for 
Healthcare Quality and Research (AHRQ) on behalf of the Department of Health and 
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Human Services (HHS), the strategy focuses on clinical quality measures used to reach 
the IOM’s six aims for improvement and the Institute for Healthcare Improvement’s 
Triple Aim of improving the experience of care, the health of the population and the per 
capita cost of care (Berwick, 2008).  Within this group, the HHS Measurement Policy 
Council was created and met in 2012 to align the identified clinical measures across all of 
the HHS federal programs and to support private sector adoption of the core measures as 
a standard for healthcare (AHRQ, 2017).  This, in combination with the passing of the 
2009 Affordable Care Act, with its move toward reimbursement based on performance, 
made it imperative to be able to show positive outcomes (Kocher, 2010). The Council, 
along with the International Consortium for Health Outcomes Measurement (ICHOM), 
has since, using randomized, controlled trials (RCTs), established validated, evidence-
based measures, including patient-reported measurement tools, for nine health conditions 
including depression (AHRQ, 2017; Porter, 2016). 
The value of measurement-based care. 
Fortney, et al. (2016), however, noted the discrepancy between the outcomes 
obtained from RCTs and those in routine care. The better outcomes from RCTs were 
directly tied to treatment protocols that included regular, systematic measurement of 
symptom acuity followed by evidence-based treatment adjustments to correct poor 
response – the foundational tenets of measurement-based care (MBC).  Harding, Rush 
and Arbuckle (2011) define MBC as “enhanced precision and consistency in disease 
assessment, tracking, and treatment to achieve optimal outcomes” (p. 1137). Fortney, et 
al. (2016), further break it down to “the systematic administration of symptom rating 
scales and use of the results to drive clinical decision making at the level of the individual 
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patient” (p.1).  Scales are not intended to substitute for clinical perception and judgment 
but rather to augment symptom assessment to improve the identification of those patients 
not responding to their current treatment regimen. The Kennedy Forum (2015) and 
Valenstein, et al. (2009) assert that the objective results validate the rationale for 
adjustments in treatment for both medication and psychotherapy-based interventions.  
However, a one-time screening for the presence of a disorder lacks effectiveness in 
monitoring treatment response. It is argued that screening must be done frequently for 
timely feedback and clinically actionable interventions to be initiated (Bickman, 2011; 
Gilbody, 2008; Hatfield, D., 2009; Priebe, 2002). Bickman (2011), Lambert, et al. (2003) 
and Reese, et al. (2009) recommend screening at each visit, using the patient-reported 
responses to increase patient involvement in care, monitor for deterioration in treatment- 
resistant patients and inform clinical decisions.   
The barriers to measurement-based care. 
Despite compelling evidence for the efficacy of measurement-based care and its 
importance in showing outcomes, data suggests it is rarely used in every day clinical 
settings (Jensen-Doss, 2018; Trivedi, 2007; Zubkoff, et al., 2012). The reasons for this 
are multiple including: the belief that clinical judgment and experience supersede the use, 
reliability and validity of a tool (Dowrick, 2009; Hatfield, 2009); the belief that the scales 
take too much time, especially with a lack of office resources (Kotte, et al., 2016; 
Meehan, 2006; Zimmerman, 2008); concerns over lack of training on the tools (Batty, et 
al., 2013; Scott, 2015; Zubkoff, 2012); concerns over patient perceptions of and 
willingness to complete the tools along with provider concern over the reduction of the 
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human element of care (Dowrick, 2009; Kotte, 2016); and skepticism over the political 
and economic motives for the use of the tools and their results (Meehan, 2006). 
   But other studies have refuted these objections.  The reliability and validity of 
most tools were well studied and founded (Beard, 2016; Guo,2017; Kroenke, 2001). 
Porter (2016) reports that Information Technology has responded with software solutions 
that can automate data collection through embedded tools in the EMR, thus streamlining 
the data gathering, aggregation and bench marking of outcomes. At least two studies 
(Trivedi, 2006; Rush, 2006) found patient ratings on depression screenings were 
equivalent to clinician-rated screening results. Dowrick (2009) found that patients 
embraced the questionnaires viewing them as an indication that the providers were taking 
their problems seriously by requesting their feedback. The economic motives have 
largely been clarified as the shift toward reimbursement for value-based care and need for 
showing positive outcomes (Fortney, 2016). Duffy, et al., (2008) strongly assert that 
integration of MBC into routine practice is feasible “even in practices with limited 
resources” (p. 1148). 
Recent studies have begun to explore ways to address clinician barriers to the use 
of MBC. Jenson-Doss (2018) found a strong link between attitudes and use. Attitudes 
varied based on age and years of experience with younger providers more open to the use 
of the measurement tools. Use was higher in settings with resources to support 
assessment or with organizational requirements to monitor progress for financial 
reporting.  Additionally, the more providers used the symptom tracking tools, the more 
value they found in their clinical use.  In an integrated primary care- mental health clinic, 
Zubkoff established that providers rarely accessed the results of patient-reported 
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measurements that were part of routine data collection with the clinic. But when provided  
current reports of their patient’s results, the clinician’s found the format very useful and 
highly recommended continuing the process. Zubkoff attested that, “Providers who had 
not been exposed to measurement-based care perceived it to be unhelpful, whereas the 
same providers found it highly valuable after brief exposure to it” (p. 92). No other 
intervention was used other than exposure to the patient’s self-reported measurements on 
the tools.  This suggests the important role of a supportive environment in increasing 
adoption of new initiatives. Evaluating the logistics of the office and formatting the 
workflow to include routine collection and reporting of measurement responses can result 
in successful implementation of MBC strategies. 
The need for measurement-based care. 
  In the United States, mental health disorders are the basis for 27% of all 
disabilities while only 6.8% of government healthcare spending is directed to psychiatric 
treatment (Vos, et al., 2012; Melek, et al., 2014). Mental health care is historically 
underfunded and may be related to the difficulty in demonstrating to payors the value of 
treatment. Without observable results, payors may perceive mental health treatment as 
having a poor return on investment compared with other medical services.  Non-profit, 
501c3, charitable organizations providing mental health services are not immune from 
this trend. Glennon, Hannibal and Meehan (2017) report how even charities are being 
held to higher accountability standards. Stiff competition for dwindling funds is driving 
the need to show positive outcomes for grant funders to justify continued financial 
support of an agency. Funders want the greatest return on their investment of donated 
dollars (Mitchell, 2016). Without this financial support, the long-term sustainability of 
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these agencies is threatened impacting the underserved population who are the 
beneficiaries of their services. It is in all these areas where measurement-based care can 
meet these needs. According to Scott (2015), regular use of MBC provides evaluative 
metrics for an organization to serve as an indicator for overall performance which can be 
compared against benchmarks and goals to substantiate a positive return on investment. 
Aim/Purpose 
The purpose of the study was to establish the use of patient-reported symptom 
measurement tools in a non-profit psychiatric clinic and determine if an office-based 
strategy to proactively and regularly report to providers their patient’s scores affected 
treatment outcomes as reflected in both score results over time and through a semi-
structured interview on provider perceptions on the impact of the reports on treatment 
planning. 
Objectives 
1. To institute the regular practice of obtaining measurements of patient-reported 
symptom scores on the PHQ-9 and GAD-7 of all patients seen at the clinic for 
either medication management or psychotherapy and embed in the new EMR. 
Goal: 90% completion rate. 
2.  To measure and compare scores on the PHQ-9 and GAD-7 both prior to and 
following an office-based intervention to provide intentional, proactive reporting 
of patient scores to providers. Goal: 10% change toward positive. 
3. To determine the effect on providers of intentional, proactive reporting of their 
patient scores toward assessment and treatment decisions. 
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Theoretical Frameworks 
Two frameworks were identified for this project. The first was Ronald Lippitt’s 
Theory of Change in Nursing which is an expanded version of Lewin’s (1951) three-step 
process involving seven steps that move in line with the nursing assessment process 
(Mitchell, 2013). It is predicated on bringing in an external change agent to put a change 
initiative in place (How to Apply, 2018). The first three phases fall under the nursing 
category of Assessment. The first phase is diagnosing the problem and developing a 
guideline for the proposed change. The second phase is assessing motivation and capacity 
for change and includes the driving and restraining forces from Lewin’s (1951) Force-
field analysis.  Phase three is assessing the change agent’s motivation and resources. 
Under Planning comes phase four with the identification of the change objective, the final 
draft of the plan and the timeline and phase five which focuses on choosing a role for the 
change agent. Change agents are active parts of the process, managing staff and 
supporting the initiative. Under Implementation is phase six where the change is 
maintained with emphasis on communication and feedback. Evaluation encompasses 
phase seven which involves terminating the helping relationship and the withdrawal of 
the change agent along with making the change permanent through policy development 
(Mitchell, 2013). 
The second framework was the Institute for Healthcare Improvement’s Model for 
Improvement (Langley, 2009). The Model for Improvement includes making small-scale 
changes using Plan-Do-Study-Act (PDSA) cycles. Each step of the project was 
performed in a distinct cycle to coincide with the framework. 
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Methods 
Project Study Design 
The study was a quality improvement, implementation initiative with an 
exploratory, mixed methods design. It entailed a pre-test/post-test quantitative 
measurement along with a semi-structured qualitative descriptive interview with 
participants following the final data collection. The intervention involved (a) the 
implementation of the standardized use of the Patient Health Questionnaire-9 (PHQ-9) 
depression screening self-report tool and the Generalized Anxiety Disorder-7 (GAD-7) 
anxiety screening self-report tool for all clients at each office visit, (b) facilitation and 
management of this process by office staff, and (c) the proactive reporting of scores to 
providers.   
Context 
The setting was a Psychiatric Clinic (Clinic) run under a non-profit community 
agency in a small mid-Atlantic city. Volunteer psychiatric providers (Nurse Practitioners 
[NP], Medical Doctors [MD], Doctors of Osteopathy [DO], third year psychiatric medical 
residents, Clinical Psychologists [PhD], Physicians Assistants [PA], Social Workers 
[SW], Registered Nurses [RN], and other psychiatric professionals) offered intake 
assessments, medication management services, the medication, itself, and psychotherapy 
to clients in a circumscribed geographic area that included two small cities and three 
counties. Clients were required to be uninsured, have incomes below 200% of the federal 
poverty level and be ineligible for services from a state agency due to the absence of 
psychiatric hospitalizations within the prior two years. Clients received services onsite at 
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the agency. Providers offered services either face-to-face or by teleconference. With one 
provider exception, psychotherapy was provided weekly. Medication evaluation and 
management visits generally occurred monthly with a few clients either bi-monthly or 
quarterly. There were 53 active clients during the study period.  
The organization maintained operations solely through the use of grant funding 
and private donations. Applications to grant funders had included the services offered and 
the number of clients served from the community but had never reported results or 
outcomes as these had never been measured. Additionally, there was no ‘graduation 
criteria’ in place to indicate that a client was stable and could be managed in a primary 
care setting. This resulted in some clients having remained at the Clinic for years, 
limiting the ability of the Clinic to reach a broader audience.  
The decision to institute a new procedure for measurement-based care was made 
by the Board of Directors of the organization as part of their strategic plan. The study 
proposal was discussed and reviewed by the Executive Director (ED) and voted on by the 
Board of Directors granting permission to proceed (See Ethics).  The clinic was moving 
from a paper-based charting system to an electronic medical record (EMR).  The PI was 
responsible for instituting the use of the EMR and developing the measurement-based 
system. As a part of the project, the PI was named as the identified superuser for the 
EMR computer program and given full access to its contents.   
All providers were given an in-person, individual training session by the PI on the 
use of the EMR for their clients. User ID’s and passwords were established. During 
training, each provider was shown the screening section of the EMR where the 
measurement tools were located and embedded and were informed that the Clinic would 
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begin using the PHQ-9 and GAD-7 as outcome measures to determine Clinic 
effectiveness. They were told that the scores would be available to see in the EMR. 
Sample 
The sample was a non-randomized convenience sample of psychiatric providers at 
the Clinic. Inclusion criteria for the study were that (a) participants be English speaking; 
(b) licensed, certified or in active training in psychiatric advanced practice, (c) actively 
seeing and following, as a provider, at least one client at the Clinic; and (d) have patient 
encounters with Clinic clients at least once per month. Exclusion criteria included (a) any 
Clinic volunteer staff who were not licensed or certified in psychiatric advanced practice, 
(b) only provided the intake assessment encounter, or (c) were active with clients less that 
a minimum of once per month. The psychiatric providers included in the study were: 
third year psychiatric medical residents in an assigned psychotherapy-only rotation (N= 
6, male (M)- 4, female (F)- 2); Licensed Psychotherapists (N=2, one Social Worker and 
one Clinical Psychologist; M- 0, F- 2); board certified psychiatric prescribers (N=6, one 
female Psychiatric-Mental Health Nurse Practitioner, one female Physician’s Assistant, 2 
DO’s, 2 MD’s; M- 2; F- 4) and one hybrid female fourth year psychiatric resident who 
volunteered providing both psychotherapy and pharmacotherapy services. All residents 
(N=7) had less than 5 years of experience in the field of Psychiatry while all other 
participants (N= 8) had over 10 years in active practice in the psychiatric field.   
 
Quantitative Procedure 
Beginning in mid-November, 2018, (Cycle 1) all clients of the clinic were 
required to complete a self-reported PHQ-9 and GAD-7 questionnaire on check-in at 
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every visit. Paper questionnaires were distributed and collected by the office manager. 
The investigator collected the questionnaires on a weekly basis and entered the scores 
into the Screening section of each client’s electronic medical record. All scores were 
available and visible to providers in the EMR. Individual scores were also maintained by 
the investigator in Excel spreadsheets separated by provider and identified by the client’s 
medical record number (MRN).  Baseline scores were established for each client  by late 
December, 2018. The second measurement datapoint (Cycle 2) for evaluation of change 
was obtained at the end of the ‘Care as Usual’ time period by capturing the last scores for 
each patient prior to the start of the reporting intervention that began in mid-March, 2019. 
Beginning on March 17, 2019 (Cycle 3), providers were sent an email from the PI 
with their clients’ trended PHQ-9 and GAD-7 scores with the explanation that, as part of 
the project, the PI would be sending these with updated information prior to each office 
visit. Scores included the total tallied score on each tool from each office visit from mid -
November onwards for each client. Clients were identified by their MRN and emailed to 
each provider on the Sunday prior to the client’s visit. Scores were randomly reported 
either in Excel spreadsheet numbers, which included the dates of the office visits, or on a 
trended graph generated by the EMR. This process was continued weekly for each client 
and each provider from mid-March to Mid-June of 2019 when the final data 
measurement of PHQ-9 and GAD-7 scores was obtained. 
Measures 
The clinical measurement tools used were the Patient Health Questionnaire-9 
(Appendix I) and the Generalized Anxiety Disorder-7 (Appendix II) screening tools 
approved for use by the Centers for Medicare and Medicaid Services as part of 
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meaningful use standards.  The PHQ-9 is a brief, self-administered, nine question, 
psychometrically validated tool based on symptom criteria from the DSM-IV for Major 
Depressive Disorder (Kroenke, 2001, Spitzer, 1999).  Each question asks about specific 
symptoms over the prior two weeks with answers on a 4-point scale rating from not at all 
to several of the days to more than half the days and finally to nearly every day. Scoring 
ranges from 0 to 3 points based on severity. The tool carries a sensitivity of 88%, a 
specificity of 88% and a Cronbach’s alpha of 0.89 for determining a diagnosis of Major 
Depression and measuring degree and changes in severity. Total tallied scores of 0-5, 5-9, 
10-14, 15-19 and 20-27 were associated with none, mild, moderate, moderately severe 
and severe depression, respectively. A score reduction of 5 points indicates a response, a 
50% reduction in score is remission and a score less than 5 is stabilization (Katzelnick, 
2011). 
The GAD-7 is a brief, self-administered seven question, psychometrically 
validated tool based on symptom criteria from the DSM-IV for Generalized Anxiety 
Disorder. The tool has a structure similar to the PHQ-9 with a 4-point rating scale with 
the same assessment distribution and an identical scoring system. The GAD-7 holds a 
sensitivity of 89% and a specificity of 82% with a Cronbach’s alpha of 0.79-0.91 
(Spitzer, 2006, Terrill, 2015, Williams, 2014). 
 
Qualitative Procedure 
An informational email was sent to all clinic providers to explain the purpose of 
the study and requesting voluntary participation in a qualitative interview. Thirteen of the 
15 providers were available and agreed to participate. Interviews took place following 
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completion of quantitative data gathering in a four-week period from mid-June 2019 
through mid-July, 2019 (Cycle 4). 
Participants were asked to sign a consent form to allow both participation and 
recording of the interviews with possible use of de-identified quotes (Appendix III). The 
PI met individually with each participant and conducted semi-structured interviews 
comprised of questions addressing attitudes, experiences and opinions on the use of 
measurement-based care, in general, and the study process, in specific.  
Qualitative Questions 
 1. Did you review the scores in the EMR prior to receiving the reports? 
2. How often and how did you use the information from the tools? 
3. What are your views on the usefulness of the information? 
4. Did you change your treatment plan in any way based on the scores? If so, how? 
5. What are your views of the usefulness of MBC outside of this clinic? 
6. Would you recommend continued use of MBC? 
Questions were reviewed by three psychiatric professionals to obtain agreement 
on internal reliability. 
 All interviews were audio-recorded using Temi recording/transcribing software 
on an iphone and lasted from 5 to 10 minutes in length. All participants were given a 
$5.00 Starbucks gift card for their participation following the end of the interview.   
  
16 
 
 
 
Analysis/Evaluation 
Quantitative analysis was performed using the Statistical Package for the Social 
Sciences (SPSS Version 26). Dependent t-tests were performed with SPSS to look for 
differences in the means of the 3 comparisons – baseline (Timepoint [TP] 1) to mid-
March (TP 2), TP 1 to mid-June (TP 3- final measurement) and TP 2 to TP 3 for both the 
PHQ-9 and GAD-7 data. A linear, repeated measures ANOVA was utilized to test the 
effect of client gender, (M,F), provider discipline (PMHNP, PA, DO, MD) and treatment 
modality (medication only, medication and psychotherapy) on scores over time. Pairwise 
comparisons were run for the effects of client gender, treatment modality and provider 
discipline within the repeated measures.  
For the qualitative analysis, transcripts of the recordings were reviewed against 
the audio-files for clarity and correction by the PI and imported into HyperResearch 
qualitative software. All transcripts were given a numeric identifier for differentiation.  
The transcribed interviews were read and re-read with constant comparison of data points 
between transcripts and against the overall interview. Codes were then generated to 
describe the focus of the points or phrases. Three independent content experts, including 
the investigator, coded the interview transcripts separately until no further codes could be 
identified and saturation was determined to have been reached. Codes from the three 
coders were synthesized and added to HyperResearch. Reports were generated on the 
frequency and means of the codes and codes were placed in a Code Map according to 
themes and sub-themes.   
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Project Timeline 
Dates Planning Pre-implementation Implementation Evaluation 
May, 2018 Meet with 
Exec. 
Director 
and Board 
of Non-
Profit to 
obtain 
approval 
   
June-
September, 
2018 
Education 
sessions 
for the PI 
to become 
a super-
user for the 
new EMR 
   
September. 
2018 
 Training sessions 
with providers to 
teach the use of new 
EMR.  
  
October 12, 
2018 
 Go-live of new 
EMR 
  
November, 
2018 
  Begin 
administering 
PHQ-9 and 
GAD-7 to 
clients 
 
January, 
2019 
  Submission 
and approval 
from IRB 
 
January 31, 
2019 
  1st datapoint 
measurement 
gathered for 
baseline scores 
of PHQ-9 and 
GAD-7 
 
 
 
March 16, 
2019 
  2nd datapoint 
measurement 
of PHQ-9 and 
GAD-7 scores; 
Begin sending 
reports to 
providers 
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Figure 1. Project Timeline 
Ethics 
Ethical considerations included that the PI was on the Board of Directors for the 
Non-Profit Organization. When proposing the study to the Board, the PI offered to step 
down from the Board for the duration of the work so that there would not be a conflict of 
interest or perceived pressure on the Board to agree to something with which they might 
privately have concerns. The Board conferred privately with the Executive Director (ED) 
and agreed that the work being proposed was in line with the strategic plan of the 
organization for the Clinic and they saw no conflict. An institutional agreement was 
already in place between the organization and JMU for use as a clinical site. There were 
no ethical concerns about the study, itself, and it posed no risks beyond normal life for 
either patients or providers. Costs incurred were covered by the PI and included time and 
the cost for the gift cards. 
Non-profit clinics often have no access to an Institutional Review Board (IRB) so 
studies can rarely be conducted in these settings. As a student, the PI had access to the 
IRB at James Madison University to review any ethical concerns. The study, protocol 
June 15, 
2019 
  Final datapoint 
measurement 
obtained of 
PHQ-9 and 
GAD-7 scores 
 
June 16 
through July 
12, 2019 
  Qualitative 
interviews 
performed 
New process put 
in place for 
sustained practice 
July through 
September, 
2019 
   Data analysis 
September, 
2019 
   Report to Board 
on findings and 
recommendations 
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#19-0768, was approved by the James Madison University IRB in January, 2019.  
Participants signed consent forms indicating their understanding of the purpose of the 
study and agreeing to the recording and possible use of de-identified quotes prior to 
participating in the qualitative interviews (Appendix III). 
For security, all paper copies of the questionnaires were shredded after entry into 
the EMR and Excel spreadsheet.  The Excel spreadsheet data was kept on a password 
protected computer at the PI’s residence only used for academics. No information was 
placed in the Cloud. The data was deleted on completion of the project. For the 
qualitative portion of the study, all recordings were erased following transcription. 
Printed transcripts were maintained in a locked cabinet in a locked office for protection 
during the analysis and shredded on completion of the study. 
Results 
Quantitative Results 
A total of 15 providers met the criteria for inclusion in the study.  The sample 
included nine females (60%) and six males (40 %). Thirteen (87%) were native English-
speaking Americans and three (13%) were foreign-born with English as a second 
language. Six (40%) were third year medical residents in a Psychiatry residency program 
and were providing psychotherapy services as part of a residency training rotation. One 
(6%) was a 4th year resident volunteering to provide both psychotherapy and medication 
management services. Two (13%) were licensed psychotherapists (1 Licensed Clinical 
Social Worker and 1 Licensed Clinical Psychologist). Six (40%) were Board certified as 
psychiatric specialists and provided medication management services only (1 PMHNP-
BC, 1 PA-SUP, 2 DO’s and 2 MD’s).  All seven residents (46.7%) had less than five 
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years of experience in the field of Psychiatry. The remaining eight licensed/certified 
providers had a minimum of ten years in the field (53.3%). There were 44 active client 
cases during the study timeframe included in the t-test results. 
Prior to analysis, descriptive statistics were run on the PHQ-9 and GAD-7 data to 
test for the assumption of normal distribution. Both sets of data satisfied the assumptions 
for normality. The PHQ-9 skew was .172 and kurtosis level was 3.065. The GAD-7 skew 
was -.874 and kurtosis level was .025. These are less than the maximum allowable values 
for a t-test of skew < 2.0 and kurtosis < 9.0 as established by Posten (1984) indicating 
that dependent samples t-tests were appropriate to conduct. 
   Paired two-tailed t-tests were used to compare the overall differences in the means 
between the three measured time points (timepoint (TP) 1 [baseline], TP 2 and TP 3 
[final]) on both the PHQ-9 and GAD-7 scores for all clients seen by the providers.  For 
the PHQ-9 scores there was a reduction in the means between each of the three time 
periods (TP-1 to TP-2, TP-2 to TP-3 and TP-1 to TP-3) but no significant difference 
found between TP-1 to TP-2 and TP-2 to TP-3. This suggests the intervention had no 
effect on the PHQ-9 depression scores. The data does, however, show a significant 
overall reduction in scores from TP-1 (M=1.043, SD= 4.796) to TP-3 (M=2.455, SD= 
6.825); t (2.386), p< .022) indicating that the clinic’s providers were effective in reducing 
symptoms of depression over the course of the 7 months of data extraction (Table 1.).   
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Table 1. 
Paired samples t-test for PHQ-9 scores 
 
Paired Samples Test 
  
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 
1 
phq1 - 
phq2 
1.04255 4.79564 .69952 -.36550 2.45061 1.490 46 .143 
Pair 
2 
phq1 - 
phq3 
2.45455 6.82490 1.02889 .37959 4.52951 2.386 43 .022 
Pair 
3 
phq2 - 
phq3 
1.05128 7.24732 1.16050 -1.29803 3.40059 .906 38 .371 
                    
 
Paired two-tailed t-tests were then performed on the GAD-7 scores for the same 
time periods. There was a more pronounced reduction in the score means between each 
of the three time period comparisons. While there was little significance between the TP-
1 and TP-2 (M=1.208, SD= 5.347); t (1.566), p= .124) measurements, there was a 
significant difference in the means during the intervention period from TP-2 to TP-3 
(M=1.949, SD= 5.844; t (2.082), p< .044) as well as from the overall TP-1 to TP-3 
measurements (M=2.910, SD= 5.242; t (3.681), p< .001). The results indicate that the 
providers were effective in reducing anxiety symptoms during the entirety of the 7-month 
time frame and that the intervention had a positive effect. 
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Table 2.  
Paired samples t-test for GAD-7 scores 
 
A linear, mixed model, repeated measures ANOVA was then performed 
separately on both the PHQ-9 and GAD-7 scores using time as the Within-Subjects 
Factor and client gender (M, F), provider discipline (NP, PA, DO/MD) and treatment 
modality (medication management alone, both medication management and 
psychotherapy) as the Between Subjects Factors.  The overall ‘N’ of active cases 
included in the ANOVA was reduced to 39 as SPSS excluded all cases with missing 
measurements.   
For the GAD-7 data, descriptive statistics were run and data satisfied the 
assumptions for Box’s Test of Equality of Covariance Matrices (p=.907), Levene’s Test 
of Equality of Error Variances (p-values = .340 for TP1, .250 for TP2, .284 for TP3) and 
Mauchley’s Test of Sphericity (p= .869). No main effects were found in the Between 
Factors measurements, however, there was a significant difference in the main effect for 
Paired Samples Test 
  
Paired Differences 
t df 
Sig. (2-
tailed) Mean 
Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 
1 
gad1 - 
gad2 
1.20833 5.34733 .77182 -.34437 2.76104 1.566 47 .124 
Pair 
2 
gad1 - 
gad3 
2.90909 5.24213 .79028 1.31534 4.50284 3.681 43 .001 
Pair 
3 
gad2 - 
gad3 
1.94872 5.84424 .93583 .05423 3.84320 2.082 38 .044 
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time displayed in the pairwise comparisons from TP1 to TP3 (F= 6.067, partial eta 
squared= .138; p < .003, CI .952-5.304) consistent with the t-test results. 
 
Table 3. 
Descriptive Statistics on GAD-7 ANOVA measurements 
 
Descriptive Statistics 
 Mean Std. Deviation N 
gad1 11.6667 5.67698 39 
gad2 10.4872 6.17240 39 
gad3 8.5385 5.81670 39 
 
Table 4. 
Pairwise comparisons of TP-1, TP-2 and TP-3 GAD-7 measurements 
 
Pairwise Comparisons 
Measure:   MEASURE_1   
(I) time (J) time 
Mean Difference 
(I-J) Std. Error Sig.b 
95% Confidence Interval for 
Differenceb 
Lower Bound Upper Bound 
1 2 1.179 .915 .616 -1.113 3.472 
3 3.128* .869 .003 .952 5.304 
2 1 -1.179 .915 .616 -3.472 1.113 
3 1.949 .936 .132 -.395 4.293 
3 1 -3.128* .869 .003 -5.304 -.952 
2 -1.949 .936 .132 -4.293 .395 
Based on estimated marginal means 
*. The mean difference is significant at the .05 level. 
b. Adjustment for multiple comparisons: Bonferroni. 
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The PHQ-9 data satisfied Box’s Test (p= .712) and Levene’s Test (p values = 
.198 for TP1, .377 for TP2 and .260 for TP3) but failed the assumption of Sphericity (p< 
.009).  (Table 5). 
 
Table 5. 
Mauchley’s test for Sphericity on PHQ-9 data indicating failure of the assumption. 
 
Mauchly's Test of Sphericitya 
Measure:   MEASURE_1 
Within Subjects 
Effect 
Mauchly's 
W 
Approx. 
Chi-Square df Sig. 
Epsilonb 
Greenhouse-
Geisser 
Huynh-
Feldt 
Lower-
bound 
time .773 9.521 2 .009 .815 .847 .500 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent 
variables is proportional to an identity matrix. 
a. Design: Intercept 
 Within Subjects Design: time 
b. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests 
are displayed in the Tests of Within-Subjects Effects table. 
  
 
A Greenhouse-Geisser correction identified a value of p< .061 for time and p< 
.184 for the time*gender interaction (Table 6). This lack of significance indicates no 
within-subjects effects. Further testing found no within-subjects or main effects for 
discipline or modality. However, a Test of Between-Subjects found a significant effect 
between genders (F(4.425, partial eta squared= .109; p< .042) (Table 7) further evidenced 
in the Estimated Marginal Means of Gender*time (Table 8). 
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Table 6. 
Greenhouse-Geisser correction for Sphericity. 
 
 
Table 7. 
Test of Between-Subjects Effects on the PHQ-9 data showing significant effect between 
genders. 
 
Tests of Between-Subjects Effects 
Measure:   MEASURE_1   
Transformed Variable:   Average   
Source 
Type III Sum of 
Squares df Mean Square F Sig. 
Partial Eta 
Squared 
Intercept 16840.909 1 16840.909 214.696 .000 .856 
Pt_Gen 347.085 1 347.085 4.425 .042 .109 
Error 2823.871 36 78.441    
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Table 8. 
Estimated Marginal Means of gender over time 
 
 
  To further explore the difference, the dataset was split between genders. Using 
univariate repeated measures for gender, differences were found within the genders, as 
well. Female scores made a steady decline resulting in a statistically significant reduction 
(p< .041, CI .130 to 7.415) overall (Table 9) and had a steeper, although not significant, 
reduction within the intervention period. Male scores had a more rapid decline in the first 
time period but rebounded in the second time period to have a statistically insignificant 
result overall. (Figure 2.). 
 
Table 9. 
Pairwise comparison of PHQ-9 scores for Female Gender over the 3 time points. 
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Figure 2. Graphed means of male (1.0) and female (2.0) scores on the PHQ-9 for all 
three timepoints. 
 
Content Analysis of Interview Responses 
Thirteen of the fifteen providers (87%) were available and willing to participate in 
qualitative interviews following the period of data gathering. Triangulation was managed 
with the use of three coders and the anonymity of the interviewees on the transcripts that 
were reviewed. The PI worked at maintaining an awareness of the intrusion of any 
preconceptions and maintained objective curiosity as to the results to address reflexivity. 
Four global themes emerged with 14 organizing themes comprised of 64 distinct codes 
with 338 references (Table 11. Frequency distribution).  The themes focused on the (a) 
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barriers to the use of MBC, (b) MBC utilization and facilitators, (c) the measurement-
based care concept, and (d) the operational process of the initiative, itself. 
 
1. Barriers to measurement-based care. 
 
1.1 Burden.  
Providers expressed some concerns about the possible burden imposed by the 
process on patients and wanted to make sure patients were willing to complete the 
forms. Concerns were also expressed about the time burden on providers seeing 
clients for medication management encounters. This was identified as being a 
problem in extending the use of MBC in their roles outside the Clinic where tight 
scheduling often limited visits to 15 minutes with little time for review of results. 
 
If I had someone that came in over the age of 60 or 65, I would usually do what’s 
called a MOCA, a Montreal Cognitive Assessment Tool, because that’s great 
utility for me to see where they are on a cognitive basis. I use those really often 
and you can’t do those in 2 minutes. 
 
So I had [different MBC tools] in my desk and I would utilize that. The only 
problem was the number of people that they wanted me to see in an hour and that 
makes it hard to cover that type of material in a 15-minute visit. 
 
“There is definitely a certain labor cost to having more forms to fill out.”  
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1.2 Choice of Appropriate Tool. 
With the variety of measurement-based tools available in Psychiatry, some 
providers questioned the use of the PHQ-9 and the GAD-7.  
 
 “I know the PHQ-9 is the kind of standard but I don’t particularly like that tool. I 
think it’s great for use with primary care but I don’t think it’s good in Psychiatry.” 
 
“Now when the government got involved in, initially, the meaningful use kind of 
stuff, the big tool was the PHQ-9 and I’m like, it’s not meaning a whole lot to 
me.” 
 
Other issues raised were over the accuracy of a self-reported tool versus one that the 
provider completed based on clinical observation. 
 
1.3  Patient Population and Diagnosis. 
Some providers raised the issue of the risk of patient abuse of the tool and its 
scoring for secondary gain. In line with this were statements regarding the emotional 
lability of patients with personality disorders whose scores could vary widely within 
the span of one day bringing into question the reliability and validity of the score. The 
underlying message was that MBC might not be appropriate for all patients and 
diagnoses.  
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“I’d have to be more careful using it in those patients because I think you can get a 
false reading.”  
1.4 Concern for Use/Depersonalizing Care. 
Some cautioned that too much emphasis on MBC ran the risk of ‘treating to the 
score’ rather than treating the patient. Some felt that the score didn’t change the 
interventions and that they didn’t require a tool to tell them what the patient was 
already stating. 
 
“I’m an old therapist so there’s times when I trust my gut better.” 
 
“Like I said, if they were miserable, they would have told me.” 
 
2. The value of measurement-based care. 
 
 2.1 Baseline measurements and markers.  
Many providers found the scores were particularly helpful in the beginning of 
treatment. Establishing a baseline measurement gave them a starting point from 
which to work and helped develop an understanding of a person that they did not 
know.  
 
“With this newer guy, he was a little harder to read and so that helped me kind of 
cue in.” 
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I think the most utility I’ve ever had with utilizing questionnaires and those types 
of tools has been upon the initial eval of a patient because I can see where they 
are from the beginning. 
 
This is something we need to utilize in certain aspects. Especially if you’re having 
a lot of problems with getting patients to really talk with you. Sometimes they’re 
more willing to sit down with a piece of paper than they are to do some face to 
face at times. It’s hard for them to verbalize exactly what they are experiencing. 
 
The scores were a way to keep track of symptoms and offer an alert for sudden 
changes. 
 
I was surprised at how depressed and anxious my patients were because they 
didn’t tell me that. Obviously, when they were given a structured questionnaire 
that was self-reported there was a difference between… I’m surprised. Yeah. 
 
“It’s quantifying. Saying the anxiety is trending up or down or the depression is 
trending up or down.” 
 
“I looked at the scores and noticed if there was a pattern.” 
 
“It’s a good standard marker for your interventions and is helpful to show 
outcomes.” 
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2.2  Guides treatment. 
The scores were used as a barometer of treatment efficacy and an indicator of 
progress. Some providers found it helped focus treatment, using the individual tool 
questions rather than the global score, as a point for discussion. Others found the lack 
of change in score results as justification for more aggressive or off-label treatment 
interventions. 
 
“I have changed the modality I use based on the patient’s scores.” 
 
So if I see the score was a little bit higher than the previous score, I kind of like 
ask the patient what happened the week prior? What changed? How come? So it 
caused me to zero in on what is happening to increase the score now. 
 
For the folks who tended to have more persistently high scores, I was more ready 
to go toward more adjunctive treatments. Things that may not have been first line 
or even officially FDA approved but had some evidence in the scientific 
literature. Having that number in my hand gave me more confidence to try 
something a bit more experimental. 
 
2.3  Use as an adjunct.  
Most described MBC’s value as that of an adjunct to their clinical judgment. It 
served as an extra datapoint against which to measure their perceptions – looking for 
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congruence between the scores and what they were seeing and experiencing with the 
client. One resident reported that the validation of their perceptions by the scores 
increased their clinical confidence. A number believed that MBC was more useful 
with pharmacotherapy rather than psychotherapy. 
 
“It’s super useful as a tool. They say medicine is an art and a science. You need a 
carpenter and a hammer.” 
 
“There’s some limitations just like anything else that’s a tool. Like anything, if 
used appropriately, it’s very useful.” 
 
“It’s another piece of data that you use in conjunction with your clinical 
judgment.” 
 
So I already had an idea of how she was doing but the PHQ-9 and GAD-7 gave 
another measurement that was validating the kind of measurement I had. And it 
was interesting that sometimes they were not necessarily the same. It gave more 
information in kind of looking at the whole thing from a different perspective, 
which I think was nice. 
 
With regards to psychotherapy, I didn’t really find myself relying too much on the 
scores to change what I was talking about because really it was kind of what they 
brought up here in the moment in the session that tended to be the focus. 
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In other clinics, I use these scales myself all the time. Especially when I am doing 
medication management and people come in and they’re like, yeah, I’m better, 
but then their scores are worse so the medication didn’t change anything. In 
measurement-based practice, I have found it to be much easier and I feel better 
about it in general. 
 
2.4  Patient-Centered Care. 
Statements emerged from providers about their patient’s responses to the 
measurements. Some felt they were receiving better care because their provider 
wanted to measure their symptoms. Others felt reviewing the change in scores with 
patients encouraged patient self-reflection and the identification of progress that they 
may not have realized. 
 
In outpatient, you’re seeing the patient every two or three months and they may 
not exactly remember how they were a few months ago. This can be sort of a 
reminder, saying, hey, you were reporting this many depressive symptoms. You 
were this bad when you started and now look where you’ve come to. 
 
I specifically told them I get that information [from the patient-completed 
questionnaire] so it gave it a purpose. They were actually interested in it. I think it 
made them feel like they were getting better care. 
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3.0  The need for measurement-based care.  
 
3.1 Evidence-based. 
In general, the providers recognized that MBC was evidence-based and the 
literature strongly supports its use. Many already used MBC in their outpatient 
practices outside the Clinic. One provider, who primarily does in-patient work in his 
main role, said it was not used much in the in-patient setting but he would like to 
begin incorporating its use in that area.  All were careful to caution scrutiny on the 
reliability and validity of the chosen tools but felt that MBC was now a standard of 
care. 
 
“I’ve had experience working in more than one place and one company didn’t use 
tools at all. That was kind of disheartening for me.” 
 
“For something such as a tried and true standardized form like the GAD-7, I 
would find any clinic suspect that didn’t employ that in some way.” 
 
 “For something as ubiquitous as the GAD-7, I think it’s invaluable. I wouldn’t 
want to do something that had no evidence behind it.” 
 
3.1 Utility. 
All providers expressed that MBC had utility in treatment. Whether using the 
global score to measure progress or the individual tool questions to jump start 
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exploration and develop behavioral activation interventions to address that one item, 
all recommended continued use of MBC. 
 
Typically, it’s easier for me to look at the questions and see how they respond…. 
And what specifically they are having difficulties with regardless of the treatment. 
We can address those in particular rather than the global type of thing. 
 
“I looked at the trajectory and how the score changed.” 
 
“There is definite utility.” 
 
4.0 Operational process of the project. 
 
4.1  Office-based mechanism. 
None of the providers looked at the scores in the EMR prior to having reports sent.  
Providers felt that having the office staff assist in facilitating the completion of the 
tools was a time saver as it didn’t encroach on the clinical time and contributed to a good 
patient response rate. However, the delay in score reporting was seen as problematic. 
At other clinics, I use these scales myself all the time. But I just imagine as soon 
as they got to the waiting room there was some on the wall and they knew that, 
okay, just take it and fill it. That saves a lot of time. 
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I wanted to share that whenever my patient was filling it in, I was usually having 
a glance at it before you sent it to us. Especially for medication management, it 
makes a huge difference whether you see it then versus two days later. 
 
4.2  EMR Use. 
The understanding of the new EMR was problematic, as well. If providers had 
difficulty accessing the program, they often wouldn’t use it during the session. Some had 
trouble finding the screening section where the scores were located. Additionally, patient 
identification on the reports that were sent was a problem as providers were unaware of 
the MRN’s of their patients. 
“I didn’t know which ones they were because I was seeing 2 people and there 
were no names. I wasn’t sure which one it was for.” 
“I glanced very briefly at the scores and found myself trying to match up the 
numbers with which patient it might refer to.” 
 
I tried to look back in my emails for the scores to see if there was a change. I 
wasn’t sure where to find the scores in the EMR. You probably told me and I 
don’t remember because I’m only there once a month. 
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4.3  Choice of Tools. 
Providers would have liked the option to use other tools. There were a number 
available in the EMR for use but, as with the category above, many were unaware that 
others existed or that they had the option to use them. Some also felt a provider-
completed tool would be more accurate. 
“I’ve always used either the HAM-D or a Beck [Depression Rating Scale], 
specifically for depression because it gave a little more detail.” 
 
      “I just worry about the subjectivity of it.” 
 
4.4  Outcome Reporting. 
Trended scores were randomly sent to providers in an Excel spreadsheet with 
dates of service and the global score on each tool for each date or in a line graph form 
generated by the EMR that covered the totality of treatment dates rather than by 
individual date. Providers varied in their preferences of reporting. Three (23%) preferred 
the Excel spreadsheet and the numbers, three (23%) had no preference and seven (54%) 
preferred the graph. 
“The graph form is more useful. There’s a better visualization of it.” 
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Figure 3. Code map 1 of qualitative interview data 
Figure 4. Code map 2 of qualitative interview data 
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Table 10. 
Means, standard deviations and frequency distribution of codes within the qualitative 
data. 
 
Project Process Results 
 
Following the phases of Lippitt’s theoretical framework, the problem was 
diagnosed in May of 2018 and a guideline for the intended change developed shortly 
thereafter once approval was received from the Board of Directors. There was substantial 
support and motivation for change on the part of the Executive Director. Driving forces 
included the need to determine the Clinic’s effectiveness for grant submissions by the 
Chief Development Officer. Restraining forces focused around the integration of the new 
41 
 
 
 
electronic health record. There was resistance from the first Clinic manager at the time 
for anything computer-related and she would occasionally forget to give clients the 
questionnaires. Some of the providers had never used an EMR and struggled with its use 
requiring more than one education session by the PI for training. Every provider had 
difficulty remembering user-id’s and passwords and needed the PI, as superuser, to re-set 
their accounts so they could gain access to the program. The PI was actively involved in 
the entire process as the primary change agent serving as computer superuser, educator, 
troubleshooter for office functions, and data manager.  
 
Instituting the use of the EMR in October allowed most of the initial problems to 
be corrected by January of 2019. This was assisted by the hire of a new office manager in 
late December, 2018 who was comfortable with the EMR and set up an organized 
process for distributing the questionnaires. Data missing from the early months created 
some difficulties with the ANOVA as SPSS would only include cases where all three 
timepoints had numbers. All cycles went according to plan with minor corrections made 
to address the issues using the PDSA framework. By March of 2019, the questionnaire 
procedure had become systematized by both the clients and office manager resulting in a 
100% completion rate. In May of 2019, the PI began to turn over some of the superuser 
functions to the office manager as part of the termination process of the helping 
relationship in Lippitt’s phase 7. Additionally, using feedback from the qualitative 
interviews, the plan was made to change the process after completion of the project 
whereby clients brought their completed questionnaires into their session to be reviewed 
and signed off by the provider. The forms were returned to the office manager at check 
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out and the office manager would add the scores into the EMR.  The results of the project 
with a statistical report on the scores and Clinic effectiveness was provided to the Board 
of Directors at the September, 2019 Board meeting. 
 
Discussion 
Measurement-based care has been recognized as evidence-based practice and an 
important aspect of care in current day healthcare and reimbursement. The primary 
problem, and one of the aims of this project, has been in accomplishing successful and 
consistent use of this practice. Few studies have focused on implementation strategies 
and tailoring the implementation to the context and setting. This project allowed for this 
from the start with (a) approval from a Non-Profit Board of Directors, (b) 
operationalization of a new EMR, (c) the embedding of measurement tools, (d) the 
establishment of an office-based process to engage clients and ensure completion and 
return of scores, and (d) a mechanism to bring those scores into the awareness of the 
provider.  Working with theoretical frameworks in a cyclic fashion kept the project on 
track with the element of time contributing to the processes becoming a routine aspect of 
daily workflow.  
The success of the project in meeting its goal and first objective (100% patient 
response rate) was largely due to the support of the Board and the engagement of the 
second office manager in generating patient acceptance of the process. As Jensen-Doss, 
et al. (2018) found, organizational factors such as the provision of resources and the drive 
to meet funder requirements are key determinants in the adoption of MBC by providers in 
these types of settings where they might not use MBC elsewhere.  
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The second objective was to compare client score changes over time to ascertain 
positive movement toward stabilization. For both depression and anxiety, the providers 
were successful- regardless of modality or discipline- in reducing distressing symptoms 
over the 7-month course of the project. These outcomes were important metrics for the 
Clinic’s effectiveness reporting. Of note in the PHQ-9, when separated, females started 
with higher score than males, indicating more symptom acuity. They were slower to 
respond but made a steady decline to a statistically significant end score. They also had a 
somewhat steeper decline during the intervention period where scores were proactively 
reported to providers.  While the steeper trajectory was not significant here, a larger ‘N’ 
might have impacted this result. Males, on the other hand, responded rapidly with 
symptom reduction but rebounded later in their care to near baseline levels. The 
significant result on the aggregated PHQ-9 scores were apparently driven primarily by 
the female clients. This unexpected finding warrants further investigation to understand 
what drives differences in treatment response based on gender. 
  The intervention had a particularly strong effect on the symptoms of anxiety. One 
possibility for this is that depression and anxiety symptoms are frequently interwoven. 
Many patients attribute the symptom cluster to depression and don’t separate the 
symptoms as distinct disorders. Once the providers saw the scores and realized that 
anxiety was a separate component of the client’s presentation, they could more actively 
address it.  Overall, awareness of the scores had an impact on treatment. 
An exploration of provider attitudes found many consistencies with the current 
literature but differences of opinion between the providers existed, as well. A circular 
paradigm seemed to be at play. Some didn’t trust the results of the patient-scored tool 
44 
 
 
 
because it was “too subjective” on the patient’s part.  Others felt they didn’t need a tool at 
all, trusting and preferring the subjective responses of what the patient would tell them. 
Others found that patients were unable to tell them and needed the tool to identify their 
concerns, coming full circle to where they would need to trust those subjective responses.  
Most did find value and utility in MBC although the value varied with the type of client 
and the tool.  Finding the right fit was important as was maintaining control over the 
choice of tool.   
Measurement-based care has been in the literature with increasing frequency over 
the last decade and, following the recommendation of Harding, Rush and Arbuckle 
(2011), is now included in residency trainings as an evidence-based practice. Possibly for 
this reason, the residents were more open to the use of these tools and were more likely to 
utilize the scores to guide treatment decisions than their older counterparts.  Most did 
feel, however, that MBC was best used in outpatient settings with pharmacotherapy 
where they had a longer timeframe to work with a client and watch for specific changes 
such as in sleep or appetite. All agreed that lack of time was the predominant detractor to 
the use of MBC, even when they really wanted to use it, so an office resource to assist in 
obtaining the scores made a great difference. They were unanimous in their 
recommendation to continue the process as long as they could see the scores at the time 
the patient completed the questionnaires. 
Given the limitations identified by the providers related to variation in tools, 
patient response, and context, all agreed that the tools were just that – tools and an 
adjunct assisting the skilled ‘carpenter’ in the work. While they are no replacement for 
experience, knowledge and expertise, they can make the work faster, easier and more 
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precise – and thus, more efficient leading to cost effectiveness.  In this era of managing 
population health, and the emphasis on meeting the 6 aims of the IOM (2001), MBC can 
make a strong contribution to the process.  
Limitations 
There were strengths and limitations within the project. A strength was that the 
Clinic was small with a consistent and dedicated group of providers willing to participate 
in this project. In addition, because of the small size, there was only one office staff 
person to educate on the new workflow. This allowed a degree of control over the 
initiation of the processes that might not exist with a larger office setting. With the 
addition of more office assistants, and with any staff turnover, there would need to be on-
going training with the risk of gaps in consistency.   
While the strength was its small size, it was also its greatest disadvantage as it 
impacts the generalizability of the findings. The major limitation to the study was the 
small sample size. Some of the results appeared to show a trend that, with a larger ‘N,’ 
might have proven significant.  Some clients who began in treatment were lost to attrition 
while new clients were added. This resulted in a compressed time period for 
measurements to have been taken, thus potentially influencing the data analysis. A year-
long time frame would have yielded stronger results. The time lag between the client 
completing the questionnaire and the provider receiving the score was problematic for 
those providers and patients who only came to the Clinic once per month or less. The 
provider was seeing scores that were a month old, inaccurately reflecting the patient’s 
current status. The maintenance workflow is designed to correct this issue such that 
providers see the scores immediately and can act on current data.  
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For the qualitative portion of the study, it would have been preferable to wait until 
the quantitative results had been analyzed before generating the semi-structured 
questions.  Questions could have been added to explore the findings related to anxiety 
and gender but would have required a resubmission to the IRB, taking additional time. 
The residents, having completed their rotation, would have moved on and been 
unavailable for interviews so the decision was made to remain with the original approved 
questions. 
Implications for Practice 
The use of the research and PDSA models where outcomes of a work process are 
regularly analyzed for response and adjusted accordingly based on those results is an 
important practice in determining efficacy. MBC assists with that by offering objective 
points for comparison measurement. The results showed the use of the measurement tools 
worked to engage the patient in a review of their own care and, as some of the providers 
found, afforded a very different view from how the providers thought they were 
progressing ultimately leading to changes in treatment and positive patient outcomes.  
The key was in the active use of it by clinicians.  
When attempting to embed MBC into treatment, a team collaboration can work 
the best with the team comprised of providers, office staff and patients engaged in their 
own care. Providers can and should choose their tools of choice based on the clients that 
they see. Office staff can manage the distribution and collection of tools, making it part 
of the routine check-in/check-out process, and later document scores in the EMR. Clients 
are educated to come prepared to be self-reflective in answering questions on their mood 
and its effects on their functional status and abilities.  
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If the active use of MBC is made difficult by time constraints, integration of its 
most timebound aspects into waiting room time and office staff workflow can facilitate 
its application. Even in the absence of an office assistant, as one provider noted, having 
the questionnaires in a wall bracket for patients to complete on arrival would work. The 
plan to have clients bring the questionnaire in to their clinician for review and sign-off 
ensures awareness of scores in real time, making them more actionable, and the process 
more likely to be sustained. Scores can then be placed in the EMR for report management 
and trending.  
The study project is worth replicating for several reasons. Use with a larger 
sample and over a longer period of time might make the significance of the intervention 
more pronounced – especially with depression in females where the intervention had a 
trending effect.  A broader grouping and number of disciplines might show how 
differences in their respective academic trainings on the use of MBC affects its continued 
implementation. This can inform academic areas as to its inclusion in curricula. MBC can 
also be used to further explore the gender difference in treatment response found in the 
data analysis. 
Conclusion 
This project was an initiative to institute MBC in a Clinic where it had not 
previously existed, remove barriers to use and, ultimately, to encourage and facilitate full 
adoption of its application into the practice.  Measurement based care can assist with 
treatment and provide outcome data but only if it is actually viewed and used to drive 
changes in care. This study showed that providers don’t actively seek out this information 
in the chart but being exposed to the scores affected their behavior and approaches to 
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treatment. Working in cycles with adjustments made along the way to overcome barriers 
was effective in incorporating the process into the normal, accepted workflow of the 
Clinic and decreased resistance to the change. The combination of quantitative measures 
showing a significant reduction in patient anxiety symptoms once providers were made 
aware of scores, and the qualitative data showing some of the highest frequency of 
comments related to the use of MBC as a barometer of treatment efficacy and its value in 
guiding treatment, make MBC worth continuing even in psychiatric practices not 
governed by the Joint Commission standards.  
The success of the implementation of MBC in this Clinic shows that even small, 
non-profits can incorporate MBC into their practices with a minor adjustment in their 
workflows and a collaborative, team approach. Ultimately, the Clinic will benefit from a 
quantification of clinical outcomes for incorporation into grant requests or insurance 
submissions. Providers will see the objective outcomes resulting from their work. And 
changes in treatment course, based on symptom feedback, will benefit patient care and 
their overall clinical success- all meeting the goals of the IOM.  
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Appendix III 
Consent to Participate in Research 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Deirdre Rea, MSN, RN from 
James Madison University.  The purpose of this study is to implement evidence-based care into 
clinical practice at Mental Health America of the Roanoke Valley (MHARV) and explore factors 
associated with the use of measurement based care by providers .  This study will contribute to 
the researcher’s completion of her Doctor of Nursing Practice final project. 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this consent 
form once all your questions have been answered to your satisfaction.  This study consists of an 
interview that will be administered to individual participants at MHARV.  You will be asked to 
provide answers to a series of questions related to your thoughts and perceptions regarding 
measurement- based care.   The interview will be recorded for accurate understanding of your 
statements.  
Time Required 
Participation in this study will require approximately 20-30 minutes of your time.   
Risks  
The investigator does not perceive more than minimal risks from your involvement in 
this study (that is, no risks beyond the risks associated with everyday life). 
Benefits 
Potential benefits from participation in this study include an understanding of any barriers to 
the use of measurement-based care by providers and whether frequent use affects adoption of 
the practice. 
Confidentiality  
The results of this research may be presented at poster/podium presentations.  The results of 
this project will be coded in such a way that the respondent’s identity will not be attached to the 
final form of this study.  The researcher retains the right to use and publish non-identifiable 
data.  While individual responses are confidential, aggregate data will be presented representing 
averages or generalizations about the responses as a whole.  All data will be stored in a secure 
location accessible only to the researcher.  Upon completion of the study, all information that 
matches up individual respondents with their answers including audio recordings will be 
destroyed.   
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Conflicts of Interest 
The researcher is a member of the Board of Directors of Mental Health Ame rica of the Roanoke 
Valley but is engaging in this study only as a student of James Madison University. The Board of 
Directors of MHARV met in private session to discuss the study and make a determination on 
any concerns for conflict of interest on the part of the researcher. The study was found to be in 
line with the goals of the clinic and the Strategic Plan of the agency so no conflict of interest was 
found and permission was granted. 
Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind.  
 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or after its 
completion or you would like to receive a copy of the final aggregate results of this study, please 
contact: 
Researcher’s Name: Deirdre Rea  Advisor’s Name: Jeannie Garber, DNP 
Department: Nursing    Department: Nursing 
James Madison University   James Madison University 
Email Address: reado@dukes.jmu.edu   Email Address: garbe2js@jmu.edu 
Telephone:  (540) 355-6478… 
Questions About Your Rights as a Research Subject 
Dr. Taimi Castle  
Chair, Institutional Review Board 
James Madison University 
(540) 568-5929 
castletl@jmu.edu  
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Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form.  I certify that I am at least 18 
years of age. 
 
 I give consent to be audio recorded during my interview.  ________ (initials)  
 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                   Date 
______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
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